Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register
- PMID: 16393765
- DOI: 10.1080/03009740510018633
Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register
Abstract
Objective: To explore the prevalence of work disability (WD) and to identify bio-psychological factors that predicts future WD in rheumatoid arthritis (RA) over a 7-year period.
Methods: Patients were selected from the Oslo RA register. The prevalence of WD was studied cross-sectionally among respondents <67 years (n = 526) in a postal survey. Mean age (SD) was 51.1 (11.9) years, mean disease duration 11.3 (9.4) years, and 49% of patients were RF-positive. The patients studied for predictive factors for WD were respondents in postal surveys both at baseline and at the 7-year follow-up, in work at baseline and still in working age (<67 years) at follow-up (n = 159). Mean age at baseline (SD) was 44.5 (9.7) years, mean disease duration 8.4 (6.6) years, mean years of formal education 12.7 (3.1) years, 48% were RF-positive. Assessments included socio-demographic variables and health status measures (MHAQ, AIMS2, SF-36, fatigue and pain on VAS 0-100 mm, self efficacy, and RAI as a measure for helplessness).
Results: Among the 526 respondents at baseline <67 years, the prevalence of WD was 40%. A high level of education was a predictor of reduced risk of work disability [odds ratio (OR) = 0.4, 95% confidence interval (CI) 0.1; 0.9], while female gender (OR 3.0, 95% CI 1.1; 8.0), physical disability (MHAQ-score) (OR = 3.9, 95% CI 1.2; 12.5) and helplessness over median RAI-score (OR = 3.0, 95% CI 1.4; 6.7) were independent predictors of increased risk for new work disability over 7 years.
Conclusion: Physical disability, increased helplessness, low formal education, and female gender were found to be independent risk factors for new work disability over the 7-year study period.
Similar articles
-
Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years.Scand J Rheumatol. 2009 May-Jun;38(3):178-83. doi: 10.1080/03009740802400594. Scand J Rheumatol. 2009. PMID: 18991183
-
The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway.J Rheumatol. 1998 Jun;25(6):1078-84. J Rheumatol. 1998. PMID: 9632067
-
[A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].Ryumachi. 2002 Feb;42(1):23-39. Ryumachi. 2002. PMID: 11925904 Japanese.
-
Markers for work disability in rheumatoid arthritis.J Rheumatol. 2001 Jul;28(7):1718-22. J Rheumatol. 2001. PMID: 11469487 Review.
-
What are the consequences of early rheumatoid arthritis for the individual?Best Pract Res Clin Rheumatol. 2005 Feb;19(1):117-36. doi: 10.1016/j.berh.2004.08.007. Best Pract Res Clin Rheumatol. 2005. PMID: 15588974 Review.
Cited by
-
Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis.Clin Rheumatol. 2010 Nov;29(11):1317-22. doi: 10.1007/s10067-010-1534-z. Epub 2010 Jul 20. Clin Rheumatol. 2010. PMID: 20645116 Free PMC article.
-
Effects of Locomotion Training on the Physical Functions and Quality of Life in Patients with Rheumatoid Arthritis: A Pilot Clinical Trial.Prog Rehabil Med. 2022 Mar 29;7:20220014. doi: 10.2490/prm.20220014. eCollection 2022. Prog Rehabil Med. 2022. PMID: 35434407 Free PMC article.
-
Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy.RMD Open. 2015 Feb 20;1(1):e000020. doi: 10.1136/rmdopen-2014-000020. eCollection 2015. RMD Open. 2015. PMID: 26509053 Free PMC article.
-
Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.Rheumatology (Oxford). 2020 Oct 1;59(10):2908-2919. doi: 10.1093/rheumatology/keaa027. Rheumatology (Oxford). 2020. PMID: 32097471 Free PMC article.
-
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).Cochrane Database Syst Rev. 2016 Nov 17;11(11):CD012437. doi: 10.1002/14651858.CD012437. Cochrane Database Syst Rev. 2016. PMID: 27855242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical